SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells<i>SRSF2</i> mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells, Published online: 01 June 2018; doi:10.1038/s41375-018-0152-7SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells

Source: Leukemia - June 1, 2018 Category: Hematology Authors: Yang Liang Toma Tebaldi Kai Rejeski Poorval Joshi Giovanni Stefani Ashley Taylor Yuanbin Song Radovan Vasic Jamie Maziarz Kunthavai Balasubramanian Anastasia Ardasheva Alicia Ding Alessandro Quattrone Stephanie Halene Source Type: research